Literature DB >> 22178039

Radiopaque drug-eluting beads for transcatheter embolotherapy: experimental study of drug penetration and coverage in swine.

Matthew R Dreher1, Karun V Sharma, David L Woods, Goutham Reddy, Yiqing Tang, William F Pritchard, Oscar A Chiesa, John W Karanian, Juan A Esparza, Danielle Donahue, Elliot B Levy, Sean L Willis, Andrew L Lewis, Bradford J Wood.   

Abstract

PURPOSE: To determine local doxorubicin levels surrounding radiopaque drug-eluting beads (DEBs) in normal swine liver and kidney following transcatheter arterial chemoembolization. The influence of bead size (70-150 μm or 100-300 μm) was compared with regard to tissue penetration and spatial distribution of the bead, as well as eventual drug coverage (ie, amount of tissue exposed to drug).
MATERIALS AND METHODS: Radiopaque DEBs were synthesized by suspension polymerization followed by incorporation of iodized oil and doxorubicin. Chemoembolization of swine liver and kidney was performed under fluoroscopic guidance. Three-dimensional tissue penetration of "imageable" DEBs was investigated ex vivo with micro-computed tomography (microCT). Drug penetration from the bead surface and drug coverage was evaluated with epifluorescence microscopy, and cellular localization of doxorubicin was evaluated with confocal microscopy. Necrosis was evaluated with hematoxylin and eosin staining.
RESULTS: MicroCT demonstrated that 70-150-μm DEBs were present in more distal arteries and located in a more frequent and homogeneous spatial distribution. Tissue penetration of doxorubicin from the bead appeared similar (∼300 μm) for both DEBs, with a maximum tissue drug concentration at 1 hour coinciding with nuclear localization of doxorubicin. The greater spatial frequency of the 70-150-μm DEBs resulted in approximately twofold improved drug coverage in kidney. Cellular death is predominantly observed around the DEBs beginning at 8 hours, but increased at 24 and 168 hours.
CONCLUSIONS: Smaller DEBs penetrated further into targeted tissue (ie, macroscopic) with a higher spatial density, resulting in greater and more uniform drug coverage (ie, microscopic) in swine.
Copyright © 2012 SIR. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22178039      PMCID: PMC3360470          DOI: 10.1016/j.jvir.2011.10.019

Source DB:  PubMed          Journal:  J Vasc Interv Radiol        ISSN: 1051-0443            Impact factor:   3.464


  40 in total

1.  Transcatheter arterial chemoembolization of liver tumors: effects of embolization protocol on injectable volume of chemotherapy and subsequent arterial patency.

Authors:  Jean-Francois H Geschwind; Douglas E Ramsey; Berry Cleffken; B C H van der Wal; Hicham Kobeiter; Krishna Juluru; George G Hartnell; Michael A Choti
Journal:  Cardiovasc Intervent Radiol       Date:  2003-03-06       Impact factor: 2.740

Review 2.  Transcatheter therapy for hepatic malignancy: standardization of terminology and reporting criteria.

Authors:  Daniel B Brown; Jennifer E Gould; Debra A Gervais; S Nahum Goldberg; Ravi Murthy; Steven F Millward; William S Rilling; Jean-Francois S Geschwind; Riad Salem; Suresh Vedantham; John F Cardella; Michael C Soulen
Journal:  J Vasc Interv Radiol       Date:  2007-12       Impact factor: 3.464

3.  Society of Interventional Radiology position statement on chemoembolization of hepatic malignancies.

Authors:  Daniel B Brown; Jean-Francois H Geschwind; Michael C Soulen; Steven F Millward; David Sacks
Journal:  J Vasc Interv Radiol       Date:  2006-02       Impact factor: 3.464

4.  First multimodal embolization particles visible on x-ray/computed tomography and magnetic resonance imaging.

Authors:  Soenke H Bartling; Johannes Budjan; Hagit Aviv; Stefan Haneder; Bettina Kraenzlin; Henrik Michaely; Shlomo Margel; Steffen Diehl; Wolfhard Semmler; Norbert Gretz; Stefan O Schönberg; Maliha Sadick
Journal:  Invest Radiol       Date:  2011-03       Impact factor: 6.016

5.  Bland embolization in patients with unresectable hepatocellular carcinoma using precise, tightly size-calibrated, anti-inflammatory microparticles: first clinical experience and one-year follow-up.

Authors:  Guido Bonomo; Vittorio Pedicini; Lorenzo Monfardini; Paolo Della Vigna; Dario Poretti; Gianluigi Orgera; Franco Orsi
Journal:  Cardiovasc Intervent Radiol       Date:  2009-12-03       Impact factor: 2.740

6.  Induction of VX2 carcinoma in rabbit liver: comparison of two inoculation methods.

Authors:  J H Chen; Y C Lin; Y S Huang; T J Chen; W Y Lin; K W Han
Journal:  Lab Anim       Date:  2004-01       Impact factor: 2.471

7.  Prospective randomized comparison of chemoembolization with doxorubicin-eluting beads and bland embolization with BeadBlock for hepatocellular carcinoma.

Authors:  Katerina Malagari; Mary Pomoni; Alexis Kelekis; Anastasia Pomoni; Spyros Dourakis; Themis Spyridopoulos; Hippokratis Moschouris; Emmanouil Emmanouil; Spyros Rizos; Dimitrios Kelekis
Journal:  Cardiovasc Intervent Radiol       Date:  2009-11-24       Impact factor: 2.740

8.  MR imaging detection of superparamagnetic iron oxide loaded tris-acryl embolization microspheres.

Authors:  Julien Namur; René Chapot; Jean-Pierre Pelage; Michel Wassef; François Langevin; Denis Labarre; Alex Laurent
Journal:  J Vasc Interv Radiol       Date:  2007-10       Impact factor: 3.464

9.  Distribution of iron oxide-containing Embosphere particles after transcatheter arterial embolization in an animal model of liver cancer: evaluation with MR imaging and implication for therapy.

Authors:  Kwang-Hun Lee; Eleni Liapi; Josephina A Vossen; Manon Buijs; Veronica Prieto Ventura; Christos Georgiades; Kelvin Hong; Ihab Kamel; Michael S Torbenson; Jean-Francois H Geschwind
Journal:  J Vasc Interv Radiol       Date:  2008-08-27       Impact factor: 3.464

10.  Prospective randomized study of doxorubicin-eluting-bead embolization in the treatment of hepatocellular carcinoma: results of the PRECISION V study.

Authors:  Johannes Lammer; Katarina Malagari; Thomas Vogl; Frank Pilleul; Alban Denys; Anthony Watkinson; Michael Pitton; Geraldine Sergent; Thomas Pfammatter; Sylvain Terraz; Yves Benhamou; Yves Avajon; Thomas Gruenberger; Maria Pomoni; Herbert Langenberger; Marcus Schuchmann; Jerome Dumortier; Christian Mueller; Patrick Chevallier; Riccardo Lencioni
Journal:  Cardiovasc Intervent Radiol       Date:  2009-11-12       Impact factor: 2.740

View more
  33 in total

Review 1.  Locoregional drug delivery using image-guided intra-arterial drug eluting bead therapy.

Authors:  Andrew L Lewis; Matthew R Dreher
Journal:  J Control Release       Date:  2012-01-21       Impact factor: 9.776

Review 2.  Advances in Biomaterials and Technologies for Vascular Embolization.

Authors:  Jingjie Hu; Hassan Albadawi; Brian W Chong; Amy R Deipolyi; Rahul A Sheth; Ali Khademhosseini; Rahmi Oklu
Journal:  Adv Mater       Date:  2019-06-06       Impact factor: 30.849

Review 3.  Bench-to-clinic development of imageable drug-eluting embolization beads: finding the balance.

Authors:  Andrew L Lewis; Sean L Willis; Matthew R Dreher; Yiqing Tang; Koorosh Ashrafi; Bradford J Wood; Elliot B Levy; Karun V Sharma; Ayele H Negussie; Andrew S Mikhail
Journal:  Future Oncol       Date:  2018-06-26       Impact factor: 3.404

4.  Characterization of a novel intrinsically radiopaque Drug-eluting Bead for image-guided therapy: DC Bead LUMI™.

Authors:  Koorosh Ashrafi; Yiqing Tang; Hugh Britton; Orianne Domenge; Delphine Blino; Andrew J Bushby; Kseniya Shuturminska; Mark den Hartog; Alessandro Radaelli; Ayele H Negussie; Andrew S Mikhail; David L Woods; Venkatesh Krishnasamy; Elliot B Levy; Bradford J Wood; Sean L Willis; Matthew R Dreher; Andrew L Lewis
Journal:  J Control Release       Date:  2017-02-08       Impact factor: 9.776

Review 5.  Systematic review of catheter-based intra-arterial therapies in hepatocellular carcinoma: state of the art and future directions.

Authors:  R Duran; J Chapiro; R E Schernthaner; J-F H Geschwind
Journal:  Br J Radiol       Date:  2015-05-15       Impact factor: 3.039

6.  Transarterial hepatic chemoembolization with 70-150 µm drug-eluting beads: assessment of clinical safety and liver toxicity profile.

Authors:  Bruno C Odisio; Aaron Ashton; Yuanqing Yan; Wei Wei; Ahmed Kaseb; Michael J Wallace; Jean N Vauthey; Sanjay Gupta; Alda L Tam
Journal:  J Vasc Interv Radiol       Date:  2015-06-05       Impact factor: 3.464

Review 7.  Polymeric materials for embolic and chemoembolic applications.

Authors:  Azadeh Poursaid; Mark Martin Jensen; Eugene Huo; Hamidreza Ghandehari
Journal:  J Control Release       Date:  2016-02-26       Impact factor: 9.776

8.  In situ forming implants exposed to ultrasound enhance therapeutic efficacy in subcutaneous murine tumors.

Authors:  Selva Jeganathan; Emily Budziszewski; Peter Bielecki; Michael C Kolios; Agata A Exner
Journal:  J Control Release       Date:  2020-05-07       Impact factor: 9.776

9.  Synthesis and characterization of polystyrene embolization particles doped with tantalum oxide nanoparticles for X-ray contrast.

Authors:  Rachel Morrison; James Thompson; Luke Bird; Mark A Hill; Helen Townley
Journal:  J Mater Sci Mater Med       Date:  2015-07-30       Impact factor: 3.896

10.  First Human Experience with Directly Image-able Iodinated Embolization Microbeads.

Authors:  Elliot B Levy; Venkatesh P Krishnasamy; Andrew L Lewis; Sean Willis; Chelsea Macfarlane; Victoria Anderson; Imramsjah Mj van der Bom; Alessandro Radaelli; Matthew R Dreher; Karun V Sharma; Ayele Negussie; Andrew S Mikhail; Jean-Francois H Geschwind; Bradford J Wood
Journal:  Cardiovasc Intervent Radiol       Date:  2016-05-20       Impact factor: 2.740

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.